Valuing QALYs at the end of life

Universidad Pablo de Olavide, Department of Economics, 2011

Autores: Jose Luis Pinto Prades, Fernando Ignacio Sánchez Martínez y Belén Corbacho



There have been changes in the way that NICE evaluates medical treatments for patients who are in the last stages of their lives. If medicines fulfil some criteria to be considered “end of life” NICE considers if QALYs gained under these circumstances should receive an extra weight.

Continuar leyendo «Valuing QALYs at the end of life»